MAINTELYTE

This brand name is authorized in Cyprus, France, Ireland, Malta, South Africa, Spain, UK.

Active ingredients

The drug MAINTELYTE contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII LX22YL083G - DEXTROSE MONOHYDRATE
 

Glucose is frequently used in both adults and children to restore blood glucose concentrations in the treatment of hypoglycaemia resulting from insulin excess or from other causes. The metabolism of glucose is an energy source for the body.

 
Read more about Glucose
2
UNII 451W47IQ8X - SODIUM CHLORIDE
 

Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue.

 
Read more about Sodium chloride
3
UNII 4550K0SC9B - SODIUM ACETATE
 
Read more about Sodium acetate
4
UNII 660YQ98I10 - POTASSIUM CHLORIDE
 

Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism.

 
Read more about Potassium chloride
5
UNII 02F3473H9O - MAGNESIUM CHLORIDE
 
Read more about Magnesium chloride

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 MAINTELYTE Solution for infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
B05BB02 Electrolytes with carbohydrates B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions → B05BB Solutions affecting the electrolyte balance
Discover more medicines within B05BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
ES Centro de información online de medicamentos de la AEMPS 84093
FR Base de données publique des médicaments 67968730
GB Medicines & Healthcare Products Regulatory Agency 379955
MT Medicines Authority MA1277/01901
ZA Health Products Regulatory Authority F/24/65, W/24/222

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.